Ross Cameron
- Hepatology top 1%
- Liver Disease and Transplantation 12
- Hepatitis C virus research 10
- Liver Diseases and Immunity 8
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 12
- Drug-Induced Hepatotoxicity and Protection 9
- Genetics top 2%
- Hematology top 2%
- Cancer Research top 5%
-
- Liver Disease Diagnosis and Treatment 25
-
- Radiopharmaceutical Chemistry and Applications 8
-
- Glutathione Transferases and Polymorphisms 8
- Co-authors
- Emmanuel FarberGary LevyDouglas M. TempletonManuela G. NeumanLaurence M. BlendisPaul D. GreigRobert A. McClellandGary M. Brittenham
- Cited by
- HepatologyPharmacologyGenetics
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Ross Cameron
102 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Hepatology 915
- Pharmacology 607
- Genetics 591
- Hematology 556
- Cancer Research 571
Countries citing papers authored by Ross Cameron
This map shows the geographic impact of Ross Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Cameron more than expected).
Fields of papers citing papers by Ross Cameron
This network shows the impact of papers produced by Ross Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Cameron. The network helps show where Ross Cameron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ross Cameron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2002 | 22 | |
| 3 | 2002 | 11 | |
| 4 | 2001 | 56 | |
| 5 | 2001 | 11 | |
| 6 | 2001 | 7 | |
| 7 | 1998 | 4 | |
| 8 | 1997 | 24 | |
| 9 | 1996 | 54 | |
| 10 | 1993 | 31 | |
| 11 | 1993 | 13 | |
| 12 | Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients. | 1993 | 5 |
| 13 | 1990 | 95 | |
| 14 | 1989 | 47 | |
| 15 | 1989 | 129 | |
| 16 | 1988 | 35 | |
| 17 | 1988 | 18 | |
| 18 | Modulation of the phenotypic expression of rat hepatocyte nodules hn by a hypolipidemic agent ciprofibrate cf | 1987 | 1 |
| 19 | Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis. | 1978 | 174 |
| 20 | A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. | 1976 | 108 |
About Ross Cameron
Ross Cameron is a scholar working on Hepatology, Pharmacology and Transplantation, having authored 103 papers that have together received 4.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (25 papers), Pharmacogenetics and Drug Metabolism (12 papers), Liver Disease and Transplantation (12 papers), Hepatitis C virus research (10 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Liver Diseases and Immunity (8 papers) and Glutathione Transferases and Polymorphisms (8 papers). The work is most often cited by research in Hepatology (915 citations), Pharmacology (607 citations) and Genetics (591 citations). Ross Cameron has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Emmanuel Farber, Gary Levy, Douglas M. Templeton, Manuela G. Neuman, Laurence M. Blendis, Paul D. Greig, Robert A. McClelland, Gary M. Brittenham, Katherine A. Vallis and Raymond M. Reilly. Their work appears in journals such as Clinical Biochemistry, Cancer Letters, Gastroenterology, Toxicologic Pathology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.